Nuevos horizontes en el desarrollo de medios de contraste en Radiología

1. Méndez R, Graña L. Fármacos en Radiología. En: del Cura JL, Pedraza S, Gayete A, editores. Radiología Esencial. Madrid: Panamericana. 2009: p.65-77.

2. Martí-Bonmatí L, Pallardó Y. Monografía SERAM- Medios de contraste en radiología. Madrid: Editorial Médica Panamericana 2008.

3. González Herrero H, De Arriba Villamor C, Buldain Parra M, Arraiza Sarasa M. Nefrotoxicidad por contrastes yodados en estudios de tomografía computarizada a pacientes ambulatorios diabéticos en tratamiento con metformina. An Sist Sanit Navar 2013: 36;………..

https://doi.org/10.4321/S1137-66272013000200003

4. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621-628.

https://doi.org/10.1148/radiology.175.3.2343107

5. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI et al. The diagnosis and management of anaphylaxis practice parameter: 2012 Update. J Allergy Clin Immunol 2010; 126: 477-480.

https://doi.org/10.1016/j.jaci.2010.06.022

6. WAO position paper. World Allergy Organization Guidelines for the Assessment and Manegement of Anphilaxys. WAO journal 2011; 4: 13-53.

7. Thomsen HS, Morcos SK. Management of acute adverse reactions to contrast media. Eur Radiol 2004; 14: 476-478.

https://doi.org/10.1007/s00330-003-2214-z

8. Quiros Y, Sánchez-González PD, López-Hernández FJ, Morales AI, López-Novoa JM. Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats. Toxicol Sci 2013, 132: 493-501.

https://doi.org/10.1093/toxsci/kft007

9. Wankhede, MW, Bouras A, Kaluzova M, Hadjipanayis CG. Magnetic nanoparticles: an emergin technology for malignant brain tumor imagin and therapy. Expert Rev Clin Pharmacol. 2012; 5: 173-186.

https://doi.org/10.1586/ecp.12.1

10. Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 2011, 121: 2768-2780.

https://doi.org/10.1172/JCI45600